Cancer Cell International is an open access, peer-reviewed, online journal that considers research on cancer cells, originating largely from work using cell culture techniques. It serves the world as a publication of the International Federation for Cell Biology. Much of cancer work relates to biolo...
Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation. The journal ...
YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)12.5253122978 202211.2-141481 202113.312-161957 202012.701453159236 20199.727536135753 20188.378555130932 20179.130632139291 20169.122648139655 20158.556506139464 20149.329679142659 20139.284670142970 20128.650625143522 ...
CANCER BIOLOGY & THERAPY 期刊简介 英文简介: Impact Factor: 3.294 Five-Year Impact Factor: 3.380 © 2017 Thomson Reuters, Journal Citation Reports ® for 2016 ranks Cancer Biology & Therapy 92 out of 217 in Oncology. Aims & Scope: Cancer, the second leading cause of death, is a heterogen...
Journal Impact Factor: 6.0 5-year Journal Impact Factor: 5.4 Source Normalized Impact per Paper (SNIP): N/A SCImago Journal Rank (SJR): N/A Speed 2023 Submission to first editorial decision (median days): 15 Submission to acceptance (median days): 149 Usage 2023 Downloads: 398,435 Altmet...
In the majority of cases, benign tumors are named by attaching the suffix-omato the name of the tissue or cell from which the cancer arose. For example, a tumor that is composed of cells related tobonecells and has the structural and biochemical properties of bone substance (osteoid) is ...
[109]). The impact of Arp2/3-WASP in cancer cell-cell fusion is unclear, but previous work suggested a substantial role of F-actin polymerization and associated cytoskeletal protein alignment to enable a permissive microenvironment for the fusion of breast cancer cells with MSC within the tumour...
L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625–634 (2010). Article CAS PubMed Google Scholar Onnis, B., Rapisarda, A. & Melillo, G. Development of HIF-1 inhibitors for cancer therapy. J. Cell. Mol. Med. 13, 2780–2786 (...
CAFs provide mechanical support and promote cancer cell growth, proliferation, metastasis, tumour angiogenesis, and contribute to tumour resistance to therapies [27]. The pro-carcinogenic property of CAFs on cancer cells is mainly influenced by secreted compounds such as stromal cell-derived factor 1 ...
treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy....